Array Biopharma, Inc. (ARRY) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $5.19 -2.99%
Financial Fact:
Research and development for proprietary programs: 46.56M
Today's EPS Names:
ITG, MTEX, NSYS, More
Financial Fact:
Research and development for proprietary programs: 46.56M
Today's EPS Names:
ITG, MTEX, NSYS, More
Join SI Premium – FREE
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q4 EPS of ($0.22), $0.01 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $6 million versus the consensus estimate of $8.1 million.
For earnings history and earnings-related data on Array Biopharma, Inc. (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Axis Capital Limited Downgrades National Aluminium (NACL:IN) to Sell (4)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
